Abbott Q1 Preview: Expect Diagnostics Business To Drive Earnings Growth
Abbott Labs is set to report its Q1 2018 earnings on April 18, and we expect the company to post solid numbers, primarily led by its Diagnostics business, reflecting the benefits of the Alere acquisition. We also expect the company’s Generic Pharmaceuticals segment to post steady growth...